Jim Laur
Chief Executive Officer at Cedars Sinai Intellectual Property Company
Los Angeles, California
Overview
Work Experience
Chief Executive Officer
2023 - Current
Managing Director
2021
Board Member
2021
Board Of Directors
2018
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.
Raised $28,350,000.00 from Blue Ox Healthcare Partners, CerraCap Ventures, Carolina Angel Network and Cedars Sinai.
Board Observer
2018
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Raised $271,339,991.00 from Qiming Venture Partners.
Vice President Intellectual Property
2017 - 2024
VP for Legal & Technology Affairs
1991 - 2024
Cedars-Sinai Health Ventures is a venture capital firm.
Board Member
2020 - 2023
Prometheus Biosciences develops and commercializes pharmaceutical and diagnostic products to help physicians individualize patient care.
Raised $951,839,507.00 from Cowen Healthcare Investments, Cedars Sinai, Nestle, AGI Partners, Cormorant Capital, RTW Investments, Eventide, Point72, Irving Investors and Perceptive Advisors.
Board Observer
2019 - 2020
Board Of Directors
2017 - 2019
Education
Doctor of Law (JD)
1983 - 1986
Bachelor of Arts (B.A.)
1979 - 1983